Precision Monitoring of Immunosuppressive Agent Concentrations in Cardiac Tissue of Pediatric Heart Transplant Recipients
Pediatric Transplantation · 2025
DOI: 10.1111/petr.70092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Kazuhisa Hashimoto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Heart Transplantation, Immunosuppressive Agents, Myocardium, Drug Monitoring. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Miyata Foundation, JSPS KAKENHI 23K07530.
Abstract (Originalsprache)
Background
Management of immunosuppressive therapy after heart transplantation is typically guided by blood trough levels. Although tissue concentrations of immunosuppressive agents reportedly correlate with acute rejection in liver and kidney allografts, data in pediatric heart transplant recipients remain limited.
Methods
We enrolled 41 pediatric heart transplant recipients who underwent follow‐up endomyocardial biopsy (EMB) between July 2021 and December 2023. For nine of those patients, serial data were collected up to 24 weeks post‐transplantation. Myocardial tissue concentrations of tacrolimus (TAC), everolimus (EVR), mycophenolic acid (MPA), and mycophenolic acid glucuronide (MPAG) were measured by liquid chromatography–tandem mass spectrometry (LC–MS/MS), while blood concentrations were quantified by LC–MS/MS or immunoassays.
Results
Significant correlations were observed between myocardial and blood concentrations at EMB for TAC ( r = 0.73, p < 0.0001), MPA ( r = 0.79, p < 0.0001), and MPAG ( r = 0.50, p < 0.0001). However, for EVR there was no significant correlation. Longitudinal analysis demonstrated that the tissue‐to‐blood TAC and EVR ratios decreased with age. No significant rejection events were observed during the study period, precluding the analysis of rejection risk.
Conclusion
Myocardial TAC, MPA, and MPAG concentrations are associated with blood levels, whereas those of EVR showed no significant correlation. Further, the tissue perfusion efficiencies of TAC and EVR decreased with age. This study highlights the value of LC–MS/MS for immunosuppressant monitoring after pediatric heart transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
- Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke, Japan.
- Jichi Medical University, Shimotsuke, Japan.
ORCID-Profile: Hidekazu Ishida
Förderung
- Miyata Foundation
- JSPS KAKENHI 23K07530
Zitieren
APA
Hashimoto, K., Kimura, N., Narita, J., Ishii, R., Hirose, M., Hayashi, K., Nishino, H., Ueyama, A., Ueda, K., Yoshihara, C., Kitabatake, Y., Nagai, R., Aizawa, K., & Ishida, H. (2025). Precision Monitoring of Immunosuppressive Agent Concentrations in Cardiac Tissue of Pediatric Heart Transplant Recipients. Pediatric Transplantation. https://doi.org/10.1111/petr.70092
Vancouver
Hashimoto K, Kimura N, Narita J, Ishii R, Hirose M, Hayashi K, et al. Precision Monitoring of Immunosuppressive Agent Concentrations in Cardiac Tissue of Pediatric Heart Transplant Recipients. Pediatric Transplantation. 2025. doi:10.1111/petr.70092
BibTeX
@article{Hashimoto2025,
author = {Hashimoto, Kazuhisa and Kimura, Natsuka and Narita, Jun and Ishii, Ryo and Hirose, Masaki and Hayashi, Ken and Nishino, Haruka and Ueyama, Atsuko and Ueda, Kazutoshi and Yoshihara, Chika and Kitabatake, Yasuji and Nagai, Ryozo and Aizawa, Kenichi and Ishida, Hidekazu},
title = {Precision Monitoring of Immunosuppressive Agent Concentrations in Cardiac Tissue of Pediatric Heart Transplant Recipients},
journal = {Pediatric Transplantation},
year = {2025},
doi = {10.1111/petr.70092}
}
EUVIMED